Jubilant Life Sciences is currently trading at Rs. 847.45, up by 2.60 points or 0.31% from its previous closing of Rs. 844.85 on the BSE.
The scrip opened at Rs. 840.00 and has touched a high and low of Rs. 853.15 and Rs. 840.00 respectively. So far 1,261 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1039.00 on 08-Feb-2018 and a 52 week low of Rs. 600.00 on 25-Oct-2017.
Last one week high and low of the scrip stood at Rs. 880.00 and Rs. 794.55 respectively. The current market cap of the company is Rs. 13,484.00 crore.
The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 29.04% and 20.28% respectively.
Jubilant Life Sciences has issued Commercial Papers (CPs) worth Rs 80 crore on May 10, 2018. The company has issued two Papers, one worth Rs 50 crore and other worth Rs 30 crore.
The tenure of instrument is 21 days for Paper worth Rs 50 crore and will mature on May 31, 2018, while the tenure of instrument is 14 days for Paper worth Rs 30 crore and will mature on May 24, 2018.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
